TheThis FDA's approval ofshows athat second generic mifepristone represents the agencyFDA properly followingfollows scientific evidence and legal requirements. Career scientists evaluated the medication's safety and effectiveness, continuing decades of established regulatory processes. This decision expands affordable healthcare options for patients, while maintaining the same safety standards that have protected women for 25 years.
TheThis FDA's reckless approval ofgives anotherthe deadlygo-ahead to a company that vows to "normalize" abortion pillto endangerscontinue endangering women and children whileand undermining state pro-life laws. These dangerous drugs can cause serious harm to mothers and aretheir 100% lethal to unborn children. TheBy approvalapproving representsthis adrug, completethe failureFDA thathas completely failed and opened the chance there will resultbe in more deaths and suffering across America.
There's a 6% chance that mifepristone will become significantly restricted or illegal to prescribe for abortions across the United States before Jan. 1, 2026, according to the Metaculus prediction community.
© 2026 Improve the News Foundation.
All rights reserved.
Version 7.4.1